Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
tRNA Activation02:26

tRNA Activation

23.7K
Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
23.7K
tRNA Activation02:26

tRNA Activation

8.9K
8.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
1.6K
Initiation of Translation02:33

Initiation of Translation

40.0K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
40.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protection of SARS-CoV-2 Infection by Targeting Viral Spike Protein With De Novo Designed ACE2-Derived Undecapeptide.

Journal of peptide science : an official publication of the European Peptide Society·2026
Same author

PATTY corrects open-chromatin bias for improved bulk and single-cell CUT&Tag profiling.

Nature communications·2026
Same author

Long Noncoding RNA Isoform Specificity and Chemical Modification on tRNA-Derived Fragments Leading to Divergent Functions.

The American journal of pathology·2026
Same author

tRF-3021a, a tRNA-Ala-TGC derived 3' fragment, promotes glioblastoma cell invasion, suppresses apoptosis, and is required for normal levels of protein synthesis.

bioRxiv : the preprint server for biology·2026
Same author

Comparative landscape of small RNAs in tissue and liquid biopsies for liver transplant outcomes.

Computational and structural biotechnology journal·2026
Same author

The chromatin regulator HELLS mediates SSB repair and responses to DNA alkylation damage.

Nucleic acids research·2025
Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
See all related articles

Related Experiment Video

Updated: Mar 20, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K

A Pro-metastatic tRNA Pathway.

Canan Kuscu1, Anindya Dutta1

  • 1Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

Cell
|June 4, 2016
PubMed
Summary
This summary is machine-generated.

Two transfer RNAs (tRNAs) are upregulated in metastatic breast cancer, enhancing the stability and translation of specific transcripts. This leads to increased production of proteins that promote cancer metastasis.

More Related Videos

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K
Experimental Metastasis Assay
08:28

Experimental Metastasis Assay

Published on: August 24, 2010

21.0K

Related Experiment Videos

Last Updated: Mar 20, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K
Experimental Metastasis Assay
08:28

Experimental Metastasis Assay

Published on: August 24, 2010

21.0K

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Transfer RNAs (tRNAs) are crucial for protein synthesis and global gene expression regulation.
  • Aberrant tRNA expression is implicated in various human diseases, including cancer.

Purpose of the Study:

  • To investigate the role of specific tRNAs in metastatic breast cancer progression.
  • To elucidate the mechanisms by which upregulated tRNAs influence gene expression in cancer cells.

Main Methods:

  • Analysis of tRNA expression profiles in metastatic breast cancer cells.
  • Assessment of transcript stability and translation efficiency for codon-enriched transcripts.
  • Identification of specific proteins whose production is modulated by tRNA upregulation.

Main Results:

  • Two specific tRNAs were found to be significantly upregulated in metastatic breast cancer cells.
  • These upregulated tRNAs enhance the stability and translation of messenger RNAs (mRNAs) containing corresponding codons.
  • This leads to an increased synthesis of pro-metastatic proteins, contributing to cancer cell invasion and spread.

Conclusions:

  • Upregulated tRNAs play a direct role in promoting breast cancer metastasis by modulating protein synthesis.
  • Targeting these specific tRNAs or their downstream effects could offer novel therapeutic strategies for metastatic breast cancer.